Supporting Health Including Endocrine Treatment for Long Duration

This research is being done to pilot an intervention which aims to test a new web- and mobile application ("app")-based supportive care tool (SHIELD portal) and to assess the feasibility of enrolling female breast cancer patients with hormone receptor-positive disease long-term endocrine treatment.

NCT Number	NCT07482384
Lead Sponsor	Dana-Farber Cancer Institute Collaborators: Breast Cancer Research Foundation
Conditions	Breast Cancer, Breast Cancer - Female, Breast Carcinoma, ER Positive Breast Cancer, PR-Positive Breast Cancer
Enrollment	30 participants
Start Date	2026-08-04
Primary Completion	2027-01 (estimated)
Study Completion	2027-05 (estimated)
Updated on ClinicalTrials.gov	2026-08-10